Price
No data yet.
Social Signal Score
Company Profile
- CEO
- Dennis Schulz
- Sector
- Financial Services
- Industry
- Asset Management - Bonds
- Employees
- 440
- Beta
- 0.97
- Country
- US
Quote
Valuation & Ratios
Returns & Efficiency
Valuation
ITMhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
50-68.75%Social Signal Score
Mentions (9)
- Newsmarketbeat.com·18d ago·Neutral
Telix Pharmaceuticals Targets $1.5B Revenue as ITM Deal Speeds Therapy Push Telix Pharmaceuticals NASDAQ: TLX outlined its commercial growth strategy, late-stage radiopharmaceutical pipeline and planned integration of ITM at an investor event in Melbourne, with management emphasizing supply-chain control, therapeutic expansion and a target to transition toward earnings growth beginning in 2028.
View source ↗ - Newsseekingalpha.com·30d ago·Positive
Telix Pharmaceuticals: The ITM Deal Could Strengthen The Long-Term Buy Case Telix Pharmaceuticals maintains a buy rating, driven by robust 3Q26 performance and the strategic ITM acquisition to diversify revenue and strengthen isotope supply. 3Q26 revenue rose 19% YoY to $245 million, with Precision Medicine up 30% YoY; Pixclara approval and pipeline advancements offer additional growth catalysts. The ITM acquisition, valued at $1.65 billion with up to $700 million in contingent payments, is expe…
View source ↗ - Newsproactiveinvestors.com·34d ago·Negative
ITM Power cuts annual losses as revenue rises 68% ITM Power PLC (AIM:ITM), the green hydrogen technology company, increased annual revenue by 68% to £43.6 million and cut its adjusted earnings losses by 39% as it expanded its project pipeline and secured government backing for new manufacturing capacity. The London-listed company reported an adjusted earnings before interest, tax, depreciation and amortisation (EBITDA) loss of £20.2 million for the financial year to 30 April, down from £33 milli…
View source ↗ - Newsproactiveinvestors.com·41d ago·Positive
ITM Power's Hydropulse signs terms for 150 MW green hydrogen project ITM Power PLC (AIM:ITM), the green hydrogen technology company, said its Hydropulse subsidiary has signed preliminary terms with a European oil refinery for a 150 megawatt project that could become its largest commercial commitment to date. The proposed development would use ITM Power's Alpha electrolyser platform to produce green hydrogen on site under a 10-year agreement.
View source ↗ - Newsproactiveinvestors.com·45d ago·Negative
ITM Power rises 5% on loss outlook as Peel Hunt keeps 'hold' ITM Power PLC (AIM:ITM) shares rose 5% to 94.00p as the electrolyser manufacturer narrowed its expected adjusted EBITDA loss for FY2026. Despite the improved guidance, Peel Hunt retained its 'hold' rating and 92.0p target price, citing continued delays to major hydrogen projects.
View source ↗ - Newsproactiveinvestors.com·45d ago·Positive
ITM Power upgrades 2026 loss guidance ahead of results ITM Power PLC (AIM:ITM), which makes electrolysers for green hydrogen production, has upgraded its loss guidance for the 2026 financial year ahead of its annual preliminary results. The company now expects an adjusted EBITDA loss of £20 million to £21 million for the year ended 30 April 2026, a 38% year-on-year improvement.
View source ↗ - Newsprnewswire.com·62d ago·Negative
Titan International Signs Definitive Agreement to Sell ITM Business to USCO S.p.A. Transaction expected to generate up to approximately $285 million in total cash value WEST CHICAGO, Ill., Sept. 21, 2026 /PRNewswire/ -- Titan International, Inc. (NYSE: TWI) ("Titan" or the "Company"), a leading global manufacturer of off-highway wheels, tires and undercarriage products, today announced that it has entered into a definitive agreement to sell its Italtractor ITM undercarriage business ("ITM") to U…
View source ↗ - Newsglobenewswire.com·63d ago·Neutral
Telix and ITM Join Forces to Create a Radiopharmaceutical Powerhouse MELBOURNE, Australia and INDIANAPOLIS and MUNICH, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces it has signed a strategic agreement to lead a merger with ITM Isotope Technologies Munich SE (“ITM”), a global leader in radioisotope production and radiopharmaceutical development.
View source ↗ - Newsreuters.com·63d ago·Positive
Australia's Telix Pharma agrees to buy Germany's ITM Isotope for about $1.65 billion Australia's Telix Pharmaceuticals said on Monday it has agreed to acquire Germany-based ITM Isotope Technologies Munich SE for about $1.65 billion on a cash- and debt-free basis.
View source ↗
Congress trades
No disclosed congressional trades in ITM.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
